KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Revenue (2016 - 2025)

Teladoc Health's Revenue history spans 12 years, with the latest figure at $642.3 million for Q4 2025.

  • For Q4 2025, Revenue changed 0.28% year-over-year to $642.3 million; the TTM value through Dec 2025 reached $2.5 billion, down 1.54%, while the annual FY2025 figure was $2.5 billion, 1.54% down from the prior year.
  • Revenue for Q4 2025 was $642.3 million at Teladoc Health, up from $626.4 million in the prior quarter.
  • Across five years, Revenue topped out at $660.5 million in Q4 2023 and bottomed at $453.7 million in Q1 2021.
  • The 5-year median for Revenue is $630.6 million (2025), against an average of $607.1 million.
  • The largest annual shift saw Revenue soared 150.93% in 2021 before it fell 3.03% in 2024.
  • A 5-year view of Revenue shows it stood at $554.2 million in 2021, then rose by 15.06% to $637.7 million in 2022, then rose by 3.58% to $660.5 million in 2023, then dropped by 3.03% to $640.5 million in 2024, then rose by 0.28% to $642.3 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Revenue are $642.3 million (Q4 2025), $626.4 million (Q3 2025), and $631.9 million (Q2 2025).